{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:17:53Z","timestamp":1790025473634,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.clml.2020.12.023","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T22:46:45Z","timestamp":1608850005000},"page":"e449-e455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis"],"prefix":"10.1016","volume":"21","author":[{"given":"Vivek","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghna","family":"Ailawadhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9683-6061","authenticated-orcid":false,"given":"Navnita","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mays","family":"Abdulazeez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4301-8561","authenticated-orcid":false,"given":"Chander Shekher","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerson","family":"Quintero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3604-5353","authenticated-orcid":false,"given":"Mizba","family":"Baksh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taimur","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Alegria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneel","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asher","family":"Chanan-Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8377-8111","authenticated-orcid":false,"given":"Sikander","family":"Ailawadhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.12.023_bib1","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clml.2020.12.023_bib2","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/leu.2016.380","article-title":"Trends in overall survival and costs of multiple myeloma, 2000-2014","volume":"31","author":"Fonseca","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2020.12.023_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4274\/Tjh.2012.0192","article-title":"Quality of life and supportive care in multiple myeloma","volume":"30","author":"Comert","year":"2013","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.clml.2020.12.023_bib4","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2020.12.023_bib5","article-title":"Racial and age-related disparities in early mortality affect the outcomes of multiple myeloma patients","author":"Covut","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2020.12.023_bib6","first-page":"172","article-title":"Risk of early death in multiple myeloma","volume":"10","author":"Kumar","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.clml.2020.12.023_bib7","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/leu.2013.313","article-title":"Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients","volume":"28","author":"Kumar","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2020.12.023_bib8","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/leu.2015.33","article-title":"Early mortality in multiple myeloma","volume":"29","author":"Costa","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2020.12.023_bib9","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1002\/ajh.23932","article-title":"Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: a study based on the nationwide Danish Myeloma Database","volume":"90","author":"Holmstrom","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.12.023_bib10","doi-asserted-by":"crossref","first-page":"e2305","DOI":"10.1097\/MD.0000000000002305","article-title":"Risk of early mortality in patients with newly diagnosed multiple myeloma","volume":"94","author":"Hsu","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"suppl 3","key":"10.1016\/j.clml.2020.12.023_bib11","doi-asserted-by":"crossref","first-page":"E42","DOI":"10.1016\/j.clml.2015.07.174","article-title":"Early mortality in elderly patients with newly diagnosed multiple myeloma treated with novel agents","volume":"15","author":"Larocca","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2020.12.023_bib12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1186\/s12885-016-2645-y","article-title":"Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen","volume":"16","author":"Jung","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clml.2020.12.023_bib13","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ajh.24389","article-title":"Early mortality in multiple myeloma: the time-dependent impact of comorbidity: a population-based study in 621 real-life patients","volume":"91","author":"Rios-Tamayo","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.12.023_bib14","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/ajh.24796","article-title":"Recognition of early mortality in multiple myeloma by a prediction matrix","volume":"92","author":"Terebelo","year":"2017","journal-title":"Am J Hematol"},{"issue":"suppl 1","key":"10.1016\/j.clml.2020.12.023_bib15","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1182\/blood-2018-99-117351","article-title":"Predicting early mortality in multiple myeloma patients treated with novel agents","volume":"132","author":"Geraldes","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.12.023_bib16","first-page":"2230","article-title":"Early mortality in elderly patients undergoing treatment for multiple myeloma in real-world practice","volume":"46","author":"Xia","year":"2018","journal-title":"J\u00a0Int Med Res"},{"issue":"15 suppl","key":"10.1016\/j.clml.2020.12.023_bib17","doi-asserted-by":"crossref","first-page":"e19509","DOI":"10.1200\/JCO.2019.37.15_suppl.e19509","article-title":"Early mortality following diagnosis of multiple myeloma from 2011 to 2016 in Alberta, Canada: initial results from the population-based Identifying Outcomes in Real-World Multiple Myeloma (INFORMM) study","volume":"37","author":"Tay","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.12.023_bib18","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1200\/JCO.2013.53.0329","volume":"32","author":"Moreau","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.12.023_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.clml.2020.12.023_bib20","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/cncr.31237","article-title":"Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: a comprehensive look at racial disparities","volume":"124","author":"Ailawadhi","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.12.023_bib21","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1182\/asheducation-2017.1.498","article-title":"Management of multiple myeloma in the newly diagnosed patient","volume":"2017","author":"Mateos","year":"2017","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clml.2020.12.023_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.clml.2019.10.002","article-title":"Treatment journeys of patients with newly diagnosed multiple myeloma (NDMM): results from the Connect MM Registry","volume":"20","author":"Jagannath","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2020.12.023_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11899-020-00570-9","article-title":"Supportive care in multiple myeloma","volume":"15","author":"Guzdar","year":"2020","journal-title":"Curr Hematol Malig Rep"},{"issue":"suppl 1","key":"10.1016\/j.clml.2020.12.023_bib24","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1182\/blood-2019-124301","article-title":"Evolving real-world treatment patterns in patients with newly-diagnosed multiple myeloma (NDMM) in the United States (US)","volume":"134","author":"Ailawadhi","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.12.023_bib25","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1182\/blood.2019000406","article-title":"With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study","volume":"133","author":"Fillmore","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.12.023_bib26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.seminoncol.2016.10.008","article-title":"A\u00a0look backward and forward in the regulatory and treatment history of multiple myeloma: approval of novel-novel agents, new drug development, and longer patient survival","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clml.2020.12.023_bib27","first-page":"HS2","article-title":"New therapies approved for multiple myeloma","volume":"41","author":"Terrie","year":"2016","journal-title":"Hospital\/Health Syst"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020310442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020310442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:36:33Z","timestamp":1761870993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020310442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2152265020310442"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.12.023","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}